Skip to main content Skip to section navigation Skip to footer
OPKO Health, Inc. Corporate homepage OPKO Health, Inc. Corporate homepage
  • Company
    • About Us
    • Team
    • Partner With Us
    • Careers
    • Contact
  • Pipeline
  • Science & Technology
    • ModeX Platforms
    • Long-Acting Biologics & Peptides
    • Publications
  • Global Pharmaceuticals
    • Our Medicines
    • Global Operations
  • Investors
    • Investors Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Governance
Site Announcement

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release
Visit BioReference Health

Press Releases

Investors

  • Investors Overview
  • News / Events
    • News / Events Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Information
    • Company Profile
    • Proxy Materials
    • Contacts
    • FAQ
  • Financial Information
    • Financial Information Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Chart
    • Historical Data
  • SEC Filings
    • SEC Filings Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Form 8937
  • Governance
    • Governance Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • News / Events Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
May 28, 2014 2:32 pm EDT
OPKO Health to Present at the Jefferies 2014 Global Healthcare Conference
May 22, 2014 9:29 am EDT
OPKO Completes Acquisition of Inspiro Medical Ltd.
May 20, 2014 10:26 am EDT
Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to Be Presented at the 2014 ICE/ENDO Meeting
May 19, 2014 3:04 pm EDT
OPKO Presents 4Kscore™ Test Clinical Study at the American Urological Association Plenary Session
May 19, 2014 2:21 pm EDT
Senesco Completes Acquisition of Fabrus, An OPKO Portfolio Company
May 12, 2014 11:20 am EDT
OPKO Licensee TESARO Announces Successful Achievement of Primary and All Secondary Endpoints in Third and Final Phase 3 Trial of Rolapitant
May 9, 2014 9:02 am EDT
OPKO Announces First Quarter Operating Results
May 8, 2014 9:26 am EDT
OPKO Announces Dismissal of PROLOR Biotech, Inc. Class Action Lawsuit
May 7, 2014 9:20 am EDT
OPKO Creates Global Supply Chain Structure
May 6, 2014 9:17 am EDT
OPKO Completes Patient Enrollment in Third Phase 3 Trial of RAYALDEE™
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • …
  • Page 55
  • Next Pagearrow_forward
rss_feed News RSS

Sign up to receive company updates straight to your inbox.

Sign Up for Email Alerts

4400 Biscayne Boulevard
Miami, FL 33137

305-575-4100 / contact@opko.com

©2026 OPKO Health, Inc. All Rights Reserved.
  • Privacy Policy
  • Terms Of Use
  • Sitemap
  • Accessibility Statement
  • Consent Preferences